South Korea
· Delayed Price · Currency is KRW SCL Science Statistics
Total Valuation
SCL Science has a market cap or net worth of KRW 65.55 billion. The enterprise value is 65.10 billion.
| Market Cap | 65.55B |
| Enterprise Value | 65.10B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SCL Science has 7.28 million shares outstanding. The number of shares has increased by 20.42% in one year.
| Shares Outstanding | 7.28M |
| Shares Change (YoY) | +20.42% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 1.55% |
| Owned by Institutions (%) | n/a |
| Float | 3.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.28 |
| PB Ratio | 3.70 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -35.57 |
| EV / Sales | 21.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.65 |
Financial Position
The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.28 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.80 |
| Interest Coverage | -7.80 |
Financial Efficiency
Return on equity (ROE) is -11.38% and return on invested capital (ROIC) is -8.74%.
| Return on Equity (ROE) | -11.38% |
| Return on Assets (ROA) | -7.58% |
| Return on Capital (ROIC) | -8.74% |
| Revenue Per Employee | 69.52M |
| Profits Per Employee | -41.59M |
| Employee Count | 44 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 5.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.76% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +6.76% |
| 50-Day Moving Average | 9,146.40 |
| 200-Day Moving Average | 9,001.75 |
| Relative Strength Index (RSI) | 45.55 |
| Average Volume (20 Days) | 6,493 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SCL Science had revenue of KRW 3.06 billion and -1.83 billion in losses. Loss per share was -265.55.
| Revenue | 3.06B |
| Gross Profit | 1.04B |
| Operating Income | -3.32B |
| Pretax Income | -1.82B |
| Net Income | -1.83B |
| EBITDA | -2.39B |
| EBIT | -3.32B |
| Loss Per Share | -265.55 |
Balance Sheet
The company has 4.90 billion in cash and 4.45 billion in debt, giving a net cash position of 452.07 million or 62.07 per share.
| Cash & Cash Equivalents | 4.90B |
| Total Debt | 4.45B |
| Net Cash | 452.07M |
| Net Cash Per Share | 62.07 |
| Equity (Book Value) | 17.71B |
| Book Value Per Share | 2,431.80 |
| Working Capital | 5.41B |
Cash Flow
In the last 12 months, operating cash flow was -2.78 billion and capital expenditures -2.81 billion, giving a free cash flow of -5.59 billion.
| Operating Cash Flow | -2.78B |
| Capital Expenditures | -2.81B |
| Free Cash Flow | -5.59B |
| FCF Per Share | -767.46 |
Margins
Gross margin is 33.95%, with operating and profit margins of -108.52% and -59.83%.
| Gross Margin | 33.95% |
| Operating Margin | -108.52% |
| Pretax Margin | -59.39% |
| Profit Margin | -59.83% |
| EBITDA Margin | -78.02% |
| EBIT Margin | -108.52% |
| FCF Margin | -182.74% |
Dividends & Yields
SCL Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.42% |
| Shareholder Yield | -20.42% |
| Earnings Yield | -2.95% |
| FCF Yield | -8.53% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCL Science has an Altman Z-Score of 3.1.
| Altman Z-Score | 3.1 |
| Piotroski F-Score | n/a |